Dr. Joy Kumar Chakma
Scientist ‘F’ & Head, Central Procurement Cell | Indian Council of Medical Research, New Delhi
In the large and often opaque architecture of India’s premier health research body, certain roles carry a weight disproportionate to their public visibility. The Central Procurement Cell (CPC) of ICMR is one such nerve centre — the institutional mechanism through which the Council acquires the equipment, diagnostics, reagents, and research infrastructure that sustains its nationwide network of institutes. At its head stands Dr. Joy Kumar Chakma, a Scientist ‘F’ — a grade that denotes both senior scientific standing and the responsibility of programme leadership — whose quarter-century of work spans epidemiological research, non-communicable disease science, and the architecture of large-scale scientific procurement.
PROFESSIONAL FORMATION
Dr. Chakma is a medical doctor with advanced specialisation in public health, bringing approximately 25 years of professional experience to his current responsibilities at ICMR headquarters, New Delhi. His scientific biography reads as that of a physician who made the deliberate and not uncostly choice to move from clinical practice into the slower, more demanding terrain of population-level research — a transition that places him squarely in the tradition of ICMR’s most consequential scientist-administrators.
His research interests are concentrated in the domain of non-communicable diseases (NCDs) and lifestyle risk factors, with particular focus on obesity, metabolic disorders, and tobacco control — including, critically, the rapidly evolving evidence base around Electronic Nicotine Delivery Systems (ENDS), commonly known as e-cigarettes and vaping devices. His engagement with air pollution and environmental health further reflects a research philosophy that situates individual pathology within its structural, social, and environmental determinants — a perspective of enduring relevance in the Indian public health context.
SNAKEBITE: THE NEGLECTED EMERGENCY
Among Dr. Chakma’s most significant recent contributions has been his involvement in ICMR’s National Task Force for Snakebite Research. Snakebite envenomation — which kills an estimated 46,000 to 58,000 Indians annually and permanently disables hundreds of thousands more — has long suffered from inadequate surveillance infrastructure, inconsistent antivenom quality, fragmented clinical management protocols, and near-total absence of community awareness. A 2025 ICMR white paper on venomous snakebite in India, prepared under the Task Force, lists Dr. Chakma among its contributors and addresses precisely these gaps — making a systematic, evidence-driven case for a national response architecture commensurate with the scale of the crisis.
His participation in this work exemplifies what distinguishes the best of ICMR’s scientist-administrators: the willingness to engage with problems that are epidemiologically urgent but institutionally unglamorous, and to deploy scientific rigour in the service of populations whose suffering has been rendered statistically invisible by the limitations of India’s health reporting infrastructure.
WHERE SCIENCE MEETS GOVERNANCE
As Head of the Central Procurement Cell, Dr. Chakma operates at a point of institutional convergence that is rarely appreciated from outside: the intersection of scientific need, quality standards, and public procurement law. ICMR’s annual report for 2024–25 records the CPC’s role in enabling the Council’s research operations — ensuring that the procurement of equipment and diagnostics across its institutes meets not only scientific specifications but also the stringent compliance requirements of India’s public financial management framework.
This is not a merely administrative function. As ICMR accelerates its programmes in indigenous diagnostic development and health-technology translation under DG Dr. Bahl’s vision of a research-driven Viksit Bharat, the CPC’s capacity to procure rapidly, compliantly, and at scale becomes a determinant of whether India’s research ambitions translate into deployed infrastructure. Dr. Chakma’s command of both the scientific and regulatory dimensions of this function makes him a pivotal — if understated — figure in ICMR’s institutional machinery.
PROFESSIONAL STANDING
Dr. Chakma has been recognised at professional forums including the Medical Research Summit and the BlackBuck Awards as a “distinguished public health specialist and epidemiologist” — epithets that, in this context, carry genuine rather than ceremonial meaning. His dual standing as active researcher and senior science administrator is increasingly rare in institutions of ICMR’s scale, where the demands of each role often come at the expense of the other. That he continues to contribute meaningfully to both tracks — NCD epidemiology and institutional governance — is a measure of professional discipline that merits recognition.




